15 Hot Penny Stocks On the Move
Strong inflation data from January and the Fed's indications that it would take its time before initiating rate cuts threw cold water on investors' hopes of getting rid of uncertainties.
Lexicon Pharmaceuticals Inc. (LXRX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Biotechnology Value Fund / BVF Inc Mark Lampert | 24,435,632 | $37,386,517 | +23% | 0.93% |
| 2. | Millennium Management Israel Englander | 1,633,176 | $2,498,759 | -58% | 0% |
| 3. | Citadel Investment Group Ken Griffin | 786,160 | $1,202,825 | +41039% | 0% |
| 4. | D E Shaw D. E. Shaw | 359,210 | $549,591 | -55% | 0% |
| 5. | Deerfield Management James E. Flynn | 103,144 | $157,810 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.05 | 90,000 | Officer, Director | 914,359 | 2023-11-16 | Filing | |
| $1.01 | 10,000 | Officer, Director | 824,359 | 2023-11-10 | Filing | |
| $1.03 | 148,820 | Director | 1,340,847 | 2023-10-12 | Filing | |
| $1.08 | 342,874 | Director | 1,192,027 | 2023-10-11 | Filing | |
| $1.14 | 508,306 | Director | 849,153 | 2023-10-10 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.93 | 12,000 | Officer | 71,766 | 2021-03-15 | Filing | |
| $6.90 | 10,912 | Officer | 71,766 | 2021-03-15 | Filing | |
| $12.91 | 10,000 | Officer | 25,643 | 2018-06-08 | Filing | |
| $15.00 | 1,500 | Officer | 15,946 | 2016-06-06 | Filing | |
| $13.00 | 6,000 | Officer | 15,946 | 2016-05-23 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 7,005,153 | $10,717,885 | 0% | |
| 2. | 5,980,371 | $9,149,968 | 0% | |
| 3. | 3,043,291 | $4,656,235 | 0% | |
| 4. | 2,382,286 | $3,644,898 | 0.24% | |
| 5. | 2,348,916 | $3,594,285 | 0% |
News See All
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Q3 2023 Earnings Call Transcript
Operator: Good day and welcome to the Lexicon Pharmaceuticals' Third Quarter 2023 Financial Results Conference Call. Today all participants will be in a listen-only mode.
15 Best Affordable Stocks To Buy Under $5
In this article, we discuss 15 best affordable stocks to buy under $5.
10 Healthcare Stocks with Insider Buying
Investors were processing inflation report on August 10 to find clues on the Federal Reserve’s possible moves. CPI’s growth in July was identical to that of June’s.
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Q2 2023 Earnings Call Transcript
Operator: Good day, and welcome to the Lexicon Pharmaceuticals Second Quarter 2023 Financial Results Conference Call. All participants will be in listen-only mode.
Hedge Fund and Insider Trading News: Chris Rokos, Dantai Capital, Bridgewater Associates, Uber Technologies, Inc. (UBER), NetSol Technologies Inc. (NTWK), and More
Chris Rokos and Deloitte have ended their legal battle over a £40m tax bill that the billionaire hedge fund manager blamed on bad advice from the Big Four firm by reaching a settlement, according to ...
Hedge Fund and Insider Trading News: Crispen Odey, Ray Dalio, Lee Ainslie, MEV Capital Management, Three Arrows Capital, Topgolf Callaway Brands Corp (MODG), Lexicon Pharmaceuticals, Inc. (LXRX), and More
Prominent London hedge-fund firm Odey Asset Management told investors it doesn't recognize "the picture of the firm that has been painted" by a Financial Times report that detailed alleged sexual misconduct...
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Q1 2023 Earnings Call Transcript
Operator: Good day everyone, and welcome to the Lexicon Pharmaceuticals First Quarter 2023 Financial Results Conference Call. All participants will be in a listen-only mode.
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Q4 2022 Earnings Call Transcript
Operator: Good afternoon, and welcome to the Lexicon Pharmaceuticals Fourth Quarter 2022 Earnings Conference Call. All participants will be in a listen-only mode.
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Q3 2022 Earnings Call Transcript
Operator: Good day, ladies and gentlemen. Welcome to the Lexicon Pharmaceuticals Inc. Third Quarter 2022 Earnings Conference Call. At this time all lines are in a listen-only mode.
Billionaire Hedge Funds
